1. Home
  2. PMAX vs CPHI Comparison

PMAX vs CPHI Comparison

Compare PMAX & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMAX
  • CPHI
  • Stock Information
  • Founded
  • PMAX 2019
  • CPHI N/A
  • Country
  • PMAX Hong Kong
  • CPHI China
  • Employees
  • PMAX N/A
  • CPHI N/A
  • Industry
  • PMAX
  • CPHI Biotechnology: Pharmaceutical Preparations
  • Sector
  • PMAX
  • CPHI Health Care
  • Exchange
  • PMAX Nasdaq
  • CPHI Nasdaq
  • Market Cap
  • PMAX 6.5M
  • CPHI 7.3M
  • IPO Year
  • PMAX 2024
  • CPHI N/A
  • Fundamental
  • Price
  • PMAX $0.42
  • CPHI $1.61
  • Analyst Decision
  • PMAX
  • CPHI
  • Analyst Count
  • PMAX 0
  • CPHI 0
  • Target Price
  • PMAX N/A
  • CPHI N/A
  • AVG Volume (30 Days)
  • PMAX 21.9M
  • CPHI 62.7K
  • Earning Date
  • PMAX 04-28-2025
  • CPHI 05-14-2025
  • Dividend Yield
  • PMAX N/A
  • CPHI N/A
  • EPS Growth
  • PMAX N/A
  • CPHI N/A
  • EPS
  • PMAX N/A
  • CPHI N/A
  • Revenue
  • PMAX $4,694,079.00
  • CPHI $4,295,377.00
  • Revenue This Year
  • PMAX N/A
  • CPHI N/A
  • Revenue Next Year
  • PMAX N/A
  • CPHI N/A
  • P/E Ratio
  • PMAX N/A
  • CPHI N/A
  • Revenue Growth
  • PMAX N/A
  • CPHI N/A
  • 52 Week Low
  • PMAX $0.28
  • CPHI $1.20
  • 52 Week High
  • PMAX $4.70
  • CPHI $3.35
  • Technical
  • Relative Strength Index (RSI)
  • PMAX N/A
  • CPHI 39.31
  • Support Level
  • PMAX N/A
  • CPHI $1.56
  • Resistance Level
  • PMAX N/A
  • CPHI $1.75
  • Average True Range (ATR)
  • PMAX 0.00
  • CPHI 0.27
  • MACD
  • PMAX 0.00
  • CPHI -0.07
  • Stochastic Oscillator
  • PMAX 0.00
  • CPHI 13.42

About PMAX Powell Max Limited Class A Ordinary Shares

Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Share on Social Networks: